We will cover an overview of Claude API's capabilities, content marketing automation strategies, implementation case studies, technical aspects of integration, and ethical considerations.

X has launched a new pay-per-use pricing model for its developer application programming interface (API), replacing the earlier pricing model that required developers to pay fixed monthly fees of up ...

MINNEAPOLIS — Federal immigration agents flooding U.S. streets are using a new surveillance tool kit whose increasing use on observers and bystanders is alarming civil liberties advocates, lawmakers ...

The anti-ICE mobilization that unfolded around the killing of Alex Pretti in Minneapolis last week mirrored the methods used to overthrow governments and spark bloody revolutions around the globe, ...

The ONLYOFFICE DocSpace SDK based on JavaScript allows developers to use all the DocSpace possibilities with api.js. You can integrate ONLYOFFICE DocSpace into your own web application, allowing users ...

Abstract: The digital era has accelerated the integration of technology into education, notably through Learning Management Systems (LMS) such as Moodle, which is widely adopted in Indonesia for its ...

This article is the latest in the Health Affairs Forefront featured topic, Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and measure ...

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

X has announced a new pay-per-use self-serve API model in hopes of luring developers back to the platform. Credit: Gabby Jones/Bloomberg via Getty Images Good news! Elon Musk's X has heard the cries ...

Starting next year, AI companies won’t be allowed to use WhatsApp as a chat interface. Here are the details. For the past few months, companies such as OpenAI and Perplexity have launched phone ...

RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open. Two ...